Selinexor for relapsed or refractory diffuse large B-cell lymphoma: examining the artifact

Lancet Haematol. 2020 Oct;7(10):e707. doi: 10.1016/S2352-3026(20)30290-8.

Authors

Stephen D Smith¹, Ajay K Gopal²

Affiliations

¹ Division of Medical Oncology and Fred Hutchinson Cancer Research Center, Clinical Research Division, University of Washington, Seattle, WA 98109, USA. Electronic address: [email protected].
² Division of Medical Oncology and Fred Hutchinson Cancer Research Center, Clinical Research Division, University of Washington, Seattle, WA 98109, USA.

PMID: 32976744
DOI: 10.1016/S2352-3026(20)30290-8

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Artifacts*
Humans
Hydrazines
Lymphoma, Large B-Cell, Diffuse*
Triazoles

Substances

Hydrazines
Triazoles
selinexor